During the past decade, CIC Clermont Ferrand conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CIC Clermont Ferrand" #1 collaborator was "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator, "Innovative clinical research network in vaccinology (I-REIVAC)" with 1 trials as a collaborator, "Observatoire Régionale de la santé ORS-PACA" with 1 trials as a collaborator and "University Hospital, Clermont-Ferrand" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CIC Clermont Ferrand" are "Atherosclerosis" (1 trials), "Cardio-metabolic Risk" (1 trials), "Cardiovascular Risk Factor" (1 trials), "Diabetes type2" (1 trials) and "Dysglycemia" (1 trials). Many other conditions were trialed in "CIC Clermont Ferrand" in a lesser frequency.

Most popular intervention types in "CIC Clermont Ferrand" are "Dietary Supplement" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo 3 intakes per day" (1 trials), "Questionnaire" (1 trials), "TOTUM-070" (1 trials), "TOTUM-63 2 intakes per day" (1 trials) and "TOTUM-63 3 intakes per day" (1 trials). Other intervention names were less common.

The vast majority of trials in "CIC Clermont Ferrand" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CIC Clermont Ferrand". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CIC Clermont Ferrand, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CIC Clermont Ferrand, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".